Legal Landscape: The Emergence of GLP-1 Vision Loss Lawsuits Against Manufacturers Like Novo Nordisk and Eli Lilly Failure to Warn: Plaintiffs across the United States have initiated legal action against pharmaceutical manufacturers Novo Nordisk and Eli Lilly, asserting that these companies failed to provide adequate warnings about vision-related risks associated with their GLP-1 receptor agonist medications
PMID: 13 NeurathMFArtisDBeckerC
Liao X, Deng T, Zhu Y, Du G, Chen J
L., Dong, Y
2024, Aug, 9;30(8):214864 Al-Aly Z, Xie Y, Bowe B
Among surgical procedures, sleeve gastrectomy and mini gastric bypass (MGB) seem to be the better choices in patients with PWS considering both the effectiveness in the achievement and maintenance of weight loss and the reduced incidence of surgical complications